Hie inhibitory function of CD4CD25+T regulatory cells is impaired in relapsing-remitting multiple sclerosis but not in primary progressive multiple sclerosis

被引：0
作者：
Putzki, Norman [1 ]
Kamou, Roulat [1 ]
Kumar, Manoj [1 ]
Kreuzfelder, Ernst [1 ]
机构：
[1] Univ Clin Essen, Dept Neurol, Essen, Germany
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S240 / S240
页数：1
相关论文
共 50 条
  • [21] CD4+CD45RO+CD49dhigh cells are involved in the pathogenesis of relapsing-remitting multiple sclerosis
    Barrau, MA
    Montalban, X
    Sáez-Torres, I
    Brieva, L
    Barberà, N
    Martínez-Cáceres, EM
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 111 (1-2) : 215 - 223
  • [22] Predictors of Conversion to Secondary Progressive Multiple Sclerosis in Patients with Relapsing-Remitting Multiple Sclerosis
    Kappos, L.
    Meier, D. P.
    Tomic, T.
    Haring, D.
    Bakshi, R.
    Meinert, R.
    Giovannoni, G.
    Chitnis, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 447 - 447
  • [23] Predictors of Conversion to Secondary Progressive Multiple Sclerosis in Patients With Relapsing-Remitting Multiple Sclerosis
    Tomic, Davorka
    Kappos, Ludwig
    Meier, Daniela Piani
    Haring, Dieter
    Meinert, Rolf
    Giovannoni, Gavin
    Chitnis, Tanuja
    NEUROLOGY, 2018, 90
  • [24] Secondary progressive in contrast to relapsing -: Remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T cell function and FOXP3 expression
    Venken, Koen
    Hellings, Niels
    Hensen, Karen
    Rummens, Jean-Luc
    Medaer, Robert
    D'hooghe, Marie B.
    Dubois, Benedicte
    Raus, Jef
    Stinissen, Piet
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 196 - 196
  • [25] Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis
    Martin, Roland
    CLINICAL IMMUNOLOGY, 2012, 142 (01) : 9 - 14
  • [26] Bioenergetics profile of CD4+ T cells in relapsing remitting multiple sclerosis subjects
    De Riccardis, Lidia
    Rizzello, Antonia
    Ferramosca, Alessandra
    Urso, Emanuela
    De Robertis, Francesca
    Danieli, Antonio
    Giudetti, Anna Maria
    Trianni, Giorgio
    Zara, Vincenzo
    Maffia, Michele
    JOURNAL OF BIOTECHNOLOGY, 2015, 202 : 31 - 39
  • [27] A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis
    Gaudino, EA
    Chiaravalloti, ND
    DeLuca, J
    Diamond, BJ
    NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY, 2001, 14 (01): : 32 - 44
  • [28] Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis
    Ratzer, R.
    Sondergaard, H. B.
    Sorensen, P. S.
    Christensen, J. C.
    Sellebjerg, F.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 131 - 132
  • [29] Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis
    Ratzer, R.
    Sondergaard, H. B.
    Christensen, J. Romme
    Bornsen, L.
    Borup, R.
    Sorensen, P. S.
    Sellebjerg, F.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (14) : 1841 - 1848
  • [30] IFNbeta-1a therapy enhances CD4+ regulatory T-cells function in a longitudinal study in relapsing-remitting multiple sclerosis patients
    de Andrés, C
    Aristimuno, C
    de las Heras, V
    Navarro, J
    Bartolomé, M
    Martínez-Ginés, M
    Arroyo, R
    Giménez-Roldán, S
    Fernández-Cruz, E
    Sánchez-Ramón, S
    MULTIPLE SCLEROSIS, 2005, 11 : S80 - S81
12345